How do index patients participating in genetic screening programmes for familial hypercholesterolemia (FH) interpret their DNA results? a UK-based qualitative interview study

Nicholas Jenkins, Julia Lawton, Margaret Douglas, Simon Walker, Robert Finnie, Mary Porteous, Nina Hallowell

Research output: Contribution to journalArticle

Abstract

Objective: To explore patients' interpretations of their DNA results for familial hypercholesterolemia (FH).

Methods: In-depth interviews were conducted with patients from two lipid clinics in Scotland, who were offered genetic testing as part of a nationwide cascade screening service.

Results: Patients were receptive to taking part in genetic screening and most expected a positive result. Receiving a molecular diagnosis of FH could provide reassurance to patients that diet and lifestyle factors were not the primary causes of their condition. Patients who received inconclusive results tended to interpret this as meaning that their high cholesterol was not genetic, which could induce feelings of uncertainty and self-blame. With the exception of newly diagnosed patients, for whom a positive result could provide a useful rationale for initiating statins, most perceived DNA screening to be of little relevance to their own medication use or their own approaches to lifestyle management.

Conclusions: Index patients are likely to view DNA screening for FH as non-threatening. Receiving a positive DNA result can be reassuring for patients. Patients may not, however, interpret inconclusive DNA results correctly.

Practice implications: Health professionals need to ensure FH index patients are prepared to receive, and fully understand, inconclusive DNA results.
Original languageEnglish
Pages (from-to)372-377
Number of pages6
JournalPatient Education and Counseling
Volume90
Issue number3
DOIs
Publication statusPublished - 1 Mar 2013
Externally publishedYes

Keywords

  • Familial hypercholesterolemia
  • Genetic testing
  • Patient perceptions
  • Inconclusive DNA results

Cite this

Jenkins, Nicholas ; Lawton, Julia ; Douglas, Margaret ; Walker, Simon ; Finnie, Robert ; Porteous, Mary ; Hallowell, Nina. / How do index patients participating in genetic screening programmes for familial hypercholesterolemia (FH) interpret their DNA results? a UK-based qualitative interview study. In: Patient Education and Counseling. 2013 ; Vol. 90, No. 3. pp. 372-377.
@article{0af567d3cc1b412ebe8087b7f8aa3fcc,
title = "How do index patients participating in genetic screening programmes for familial hypercholesterolemia (FH) interpret their DNA results?: a UK-based qualitative interview study",
abstract = "Objective: To explore patients' interpretations of their DNA results for familial hypercholesterolemia (FH). Methods: In-depth interviews were conducted with patients from two lipid clinics in Scotland, who were offered genetic testing as part of a nationwide cascade screening service. Results: Patients were receptive to taking part in genetic screening and most expected a positive result. Receiving a molecular diagnosis of FH could provide reassurance to patients that diet and lifestyle factors were not the primary causes of their condition. Patients who received inconclusive results tended to interpret this as meaning that their high cholesterol was not genetic, which could induce feelings of uncertainty and self-blame. With the exception of newly diagnosed patients, for whom a positive result could provide a useful rationale for initiating statins, most perceived DNA screening to be of little relevance to their own medication use or their own approaches to lifestyle management. Conclusions: Index patients are likely to view DNA screening for FH as non-threatening. Receiving a positive DNA result can be reassuring for patients. Patients may not, however, interpret inconclusive DNA results correctly. Practice implications: Health professionals need to ensure FH index patients are prepared to receive, and fully understand, inconclusive DNA results.",
keywords = "Familial hypercholesterolemia, Genetic testing, Patient perceptions, Inconclusive DNA results",
author = "Nicholas Jenkins and Julia Lawton and Margaret Douglas and Simon Walker and Robert Finnie and Mary Porteous and Nina Hallowell",
year = "2013",
month = "3",
day = "1",
doi = "10.1016/j.pec.2011.09.002",
language = "English",
volume = "90",
pages = "372--377",
journal = "Patient Education and Counseling",
issn = "0738-3991",
publisher = "Elsevier B.V.",
number = "3",

}

How do index patients participating in genetic screening programmes for familial hypercholesterolemia (FH) interpret their DNA results? a UK-based qualitative interview study. / Jenkins, Nicholas; Lawton, Julia; Douglas, Margaret; Walker, Simon; Finnie, Robert; Porteous, Mary; Hallowell, Nina.

In: Patient Education and Counseling, Vol. 90, No. 3, 01.03.2013, p. 372-377.

Research output: Contribution to journalArticle

TY - JOUR

T1 - How do index patients participating in genetic screening programmes for familial hypercholesterolemia (FH) interpret their DNA results?

T2 - a UK-based qualitative interview study

AU - Jenkins, Nicholas

AU - Lawton, Julia

AU - Douglas, Margaret

AU - Walker, Simon

AU - Finnie, Robert

AU - Porteous, Mary

AU - Hallowell, Nina

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Objective: To explore patients' interpretations of their DNA results for familial hypercholesterolemia (FH). Methods: In-depth interviews were conducted with patients from two lipid clinics in Scotland, who were offered genetic testing as part of a nationwide cascade screening service. Results: Patients were receptive to taking part in genetic screening and most expected a positive result. Receiving a molecular diagnosis of FH could provide reassurance to patients that diet and lifestyle factors were not the primary causes of their condition. Patients who received inconclusive results tended to interpret this as meaning that their high cholesterol was not genetic, which could induce feelings of uncertainty and self-blame. With the exception of newly diagnosed patients, for whom a positive result could provide a useful rationale for initiating statins, most perceived DNA screening to be of little relevance to their own medication use or their own approaches to lifestyle management. Conclusions: Index patients are likely to view DNA screening for FH as non-threatening. Receiving a positive DNA result can be reassuring for patients. Patients may not, however, interpret inconclusive DNA results correctly. Practice implications: Health professionals need to ensure FH index patients are prepared to receive, and fully understand, inconclusive DNA results.

AB - Objective: To explore patients' interpretations of their DNA results for familial hypercholesterolemia (FH). Methods: In-depth interviews were conducted with patients from two lipid clinics in Scotland, who were offered genetic testing as part of a nationwide cascade screening service. Results: Patients were receptive to taking part in genetic screening and most expected a positive result. Receiving a molecular diagnosis of FH could provide reassurance to patients that diet and lifestyle factors were not the primary causes of their condition. Patients who received inconclusive results tended to interpret this as meaning that their high cholesterol was not genetic, which could induce feelings of uncertainty and self-blame. With the exception of newly diagnosed patients, for whom a positive result could provide a useful rationale for initiating statins, most perceived DNA screening to be of little relevance to their own medication use or their own approaches to lifestyle management. Conclusions: Index patients are likely to view DNA screening for FH as non-threatening. Receiving a positive DNA result can be reassuring for patients. Patients may not, however, interpret inconclusive DNA results correctly. Practice implications: Health professionals need to ensure FH index patients are prepared to receive, and fully understand, inconclusive DNA results.

KW - Familial hypercholesterolemia

KW - Genetic testing

KW - Patient perceptions

KW - Inconclusive DNA results

U2 - 10.1016/j.pec.2011.09.002

DO - 10.1016/j.pec.2011.09.002

M3 - Article

VL - 90

SP - 372

EP - 377

JO - Patient Education and Counseling

JF - Patient Education and Counseling

SN - 0738-3991

IS - 3

ER -